U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 10 results

Status:
US Approved Rx (2016)
First marketed in 1912

Class (Stereo):
CHEMICAL (ACHIRAL)


Barium sulfate, an insoluble in water substance, which was approved under the brand name E-Z-HD for use in double-contrast radiographic examinations of the esophagus, stomach and duodenum to visualize the gastrointestinal (GI) tract in patients 12 y...
Status:
US Approved Rx (2022)
First marketed in 1912

Class (Stereo):
CHEMICAL (ACHIRAL)



Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...
Status:
US Previously Marketed
First marketed in 1912

Class (Stereo):
CHEMICAL (ACHIRAL)



Ellagic acid is a dilactone of hexahydroxydiphenic acid, that found in numerous fruits and vegetables. Ellagic acid was first discovered by chemist Henri Braconnot in 1831. Ellagic acid is found in oaks species like the North American white oak (Quer...
Status:
US Previously Marketed
First marketed in 1912

Class (Stereo):
CHEMICAL (ACHIRAL)

Neoarsphenamine and related compounds are sulfhydryl-binding agents which are tolerated by man. A large experience in the employment of this drug and its toxic manifestations exists as a result of its former use as an antisyphilitic agent. Tertiary s...
Status:
US Approved Rx (2022)
First marketed in 1912

Class (Stereo):
CHEMICAL (ACHIRAL)



Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...
Status:
US Approved Rx (2022)
First marketed in 1912

Class (Stereo):
CHEMICAL (ACHIRAL)



Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...
Status:
US Approved Rx (2022)
First marketed in 1912

Class (Stereo):
CHEMICAL (ACHIRAL)



Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...
Status:
US Approved Rx (2022)
First marketed in 1912

Class (Stereo):
CHEMICAL (ABSOLUTE)



Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...
Status:
US Approved Rx (2022)
First marketed in 1912

Class (Stereo):
CHEMICAL (ACHIRAL)



Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...
Status:
US Previously Marketed
First marketed in 1912

Class (Stereo):
CHEMICAL (ACHIRAL)

Neoarsphenamine and related compounds are sulfhydryl-binding agents which are tolerated by man. A large experience in the employment of this drug and its toxic manifestations exists as a result of its former use as an antisyphilitic agent. Tertiary s...